Abstract

Influenza B viruses (IBVs) cause substantive morbidity and mortality, and yet immunity towards IBVs remains understudied. CD8+ T-cells provide broadly cross-reactive immunity and alleviate disease severity by recognizing conserved epitopes. Despite the IBV burden, only 18 IBV-specific T-cell epitopes restricted by 5 HLAs have been identified currently. A broader array of conserved IBV T-cell epitopes is needed to develop effective cross-reactive T-cell based IBV vaccines. Here we identify 9 highly conserved IBV CD8+ T-cell epitopes restricted to HLA-B*07:02, HLA-B*08:01 and HLA-B*35:01. Memory IBV-specific tetramer+CD8+ T-cells are present within blood and tissues. Frequencies of IBV-specific CD8+ T-cells decline with age, but maintain a central memory phenotype. HLA-B*07:02 and HLA-B*08:01-restricted NP30-38 epitope-specific T-cells have distinct T-cell receptor repertoires. We provide structural basis for the IBV HLA-B*07:02-restricted NS1196-206 (11-mer) and HLA-B*07:02-restricted NP30-38 epitope presentation. Our study increases the number of IBV CD8+ T-cell epitopes, and defines IBV-specific CD8+ T-cells at cellular and molecular levels, across tissues and age.

Influenza B viruses are linked to significant morbidity and mortality, and yet their immunobiology is comparatively poorly understood. Here Menon et al identify influenza B virus-specific CD8+ T cell epitopes and characterise these in adults, children and the elderly.

Details

Title
CD8+ T-cell responses towards conserved influenza B virus epitopes across anatomical sites and age
Author
Menon, Tejas 1   VIAFID ORCID Logo  ; Illing, Patricia T. 2   VIAFID ORCID Logo  ; Chaurasia, Priyanka 2 ; McQuilten, Hayley A. 1   VIAFID ORCID Logo  ; Shepherd, Chloe 2 ; Rowntree, Louise C. 1   VIAFID ORCID Logo  ; Petersen, Jan 2 ; Littler, Dene R. 2   VIAFID ORCID Logo  ; Khuu, Grace 2 ; Huang, Ziyi 2 ; Allen, Lilith F. 1 ; Rockman, Steve 3 ; Crowe, Jane 4 ; Flanagan, Katie L. 5   VIAFID ORCID Logo  ; Wakim, Linda M. 1 ; Nguyen, Thi H. O. 1   VIAFID ORCID Logo  ; Mifsud, Nicole A. 2   VIAFID ORCID Logo  ; Rossjohn, Jamie 6   VIAFID ORCID Logo  ; Purcell, Anthony W. 2   VIAFID ORCID Logo  ; van de Sandt, Carolien E. 7   VIAFID ORCID Logo  ; Kedzierska, Katherine 1   VIAFID ORCID Logo 

 University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
 Monash University, Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
 University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); CSL Seqirus Ltd, Parkville, Australia (GRID:grid.1008.9) 
 Deepdene Surgery, Deepdene, Australia (GRID:grid.1008.9) 
 Launceston General Hospital, Tasmanian Vaccine Trial Centre, Launceston, Australia (GRID:grid.415834.f) (ISNI:0000 0004 0418 6690); University of Tasmania, School of Health Sciences and School of Medicine, Launceston, Australia (GRID:grid.1009.8) (ISNI:0000 0004 1936 826X); RMIT University, School of Health and Biomedical Science, Melbourne, Australia (GRID:grid.1017.7) (ISNI:0000 0001 2163 3550) 
 Monash University, Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Cardiff University School of Medicine, Institute of Infection and Immunity, Cardiff, UK (GRID:grid.5600.3) (ISNI:0000 0001 0807 5670) 
 University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262) 
Pages
3387
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3048257329
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.